Fig 1.
The PRISMA flowchart provides an overview of the article selection process, detailing the steps of identification, screening, eligibility assessment, and final inclusion of studies.
Table 1.
Evaluation of publication bias in meta-analysis.
Fig 2.
A forest plot depicting the overall proportion of antibiotic-resistant Elizabethkingia isolates (Ceftazidime, Rifampin, Ciprofloxacin, Cefotaxime, Meropenem, Gentamicin, and Sulfamethoxazole), calculated using a random-effects model.
Fig 3.
Funnel plots for assessing publication bias in antibiotic resistance studies.
These plots visualize the relationship between study precision and effect estimates for various antibiotics. The symmetrical distribution around the central vertical line indicates minimal publication bias. To address potential asymmetry, the trim-and-fill method was applied. This method involves imputing studies for symmetry, represented by white circles. The adjusted resistance proportions post-Trim and Fill are as follows: Ceftazidime (0.703, 95%CI 0.144-0.971), Rifampin (0.185, 95%CI 0.095-0.330), Ciprofloxacin (0.372, 95%CI 0.203-0.580), Cefotaxime (0.968, 95%CI 0.934-0.985), Meropenem (0.880, 95%CI 0.753-0.946), and Gentamicin (0.557, 95%CI 0.327-0.764).